REFERENCES
- Fee WE, Glenn M, Handen C, Hopp ML. One day vs. two days of prophylactic antibiotics in patients undergoing major head and neck surgery. Laryngoscope 1984; 94: 612–4.
- Johnson JT, Myers EN, Thearle PB, Sigler BA, Schramm VL. Antimicrobial prophylaxis for contaminated head and neck surgery. Laryngoscope 1984; 94: 46–51.
- Johnson JT, Schuller DE, Silver F et al. Antibiotic pro-phylaxis in high-risk head and neck surgery: one-day vs. five-day therapy. Otolaryngol Head Neck Surg 1986; 95: 554–7.
- Gehanno P, Moisy N, Guedon C. Cefotaxime in the prophylaxis of otolaryngological cancer surgery. Long term versus short term administration. Results of a multicentre study. Drugs 1988; 35 (Suppl. 2):111-5.
- Piccart M, Dor P, Klastersky J. Antimicrobial prophy-laxis of infections in head and neck cancer surgery. Scand J Infect Dis 1983; 39: 92–6.
- Sawyer R, Cozzi L, Rosenthal DI, Maniglia AJ. Metronidazole in head and neck surgery. The effect of lenght-ened prophylaxis. Otolaryngol Head Neck Surg 1990; 103: 1009–11.
- Dominici L, Gondret R, Broc V, Dubos S, Viallard M, Deligne P. Antimicrobial prophylaxis for major head and neck cancer surgery with piperacillin and ornidazole. J Laryngol Otol 1992; 106: 409–11.
- Tandon DA, Bahadur S, Laldina HC, Sundaram KR. Role of prophylactic antibiotics in surgery for advanced head and neck cancer. J Laryngol Otol 1992; 106: 621–4.
- Russier M, Mirault F, Champroux T, Leclercq I, Gaillard de Collogny L, Lafaye M. Prevention des complica-tions infectieuses de la chirurgie majeure des cancers des voies aero-digestives superieures par l'association: pefloxacine-amoxicilline acide davulanique. Ann Otolaryng (Paris) 1990; 107: 406–10.
- Johnson JT, Yu VL. Role of aerobic gram-negative rods, anaerobes, and fungi in wound infection after head and neck surgery: implications for antibiotic prophylaxis. Head Neck 1989; 11: 27–9.
- Johnson JT, Yu VL, Myers EN, Wagner RL. An assess-ment of the need for gram-negative bacterial coverage in antibiotic prophylaxis for oncological head and neck surgery. J Infect Dis 1987; 155: 331–3.
- Weber RS, Raad I, Frankenthaler R, et al. Ampicillin-sulbactam vs. clindamycin in head and neck oncologic surgery. The need for gram-negative coverage. Arch Otolaryngol Head Neck Surg 1992; 118: 1159–63.
- Shapiro M. Prophylaxis in otolaryngologic surgery and neurosurgery: a critical review. Rev Infect Dis 1991; 13 (Suppl. 10):5858-68.
- Weber RS, Callender AL. Antibiotic prophylaxis in clean-contaminated head and neck oncologic surgery. Ann Otol Rhinol Laryngol 1992; 101: 16–20.
- Tabet JC, Johnson JT. Wound infection in head and neck surgery: prophylaxis, etiology and management. J Otolaryngol 1990; 19: 197–200.
- Robbins KT, Faurot S, Hanna D, Cole R. Risk of wound infection in patients with head and neck cancer. Head Neck 1990; 12: 143–8.
- Brown BM, Johnson JT, Wagner RL. Etiologic factors in head and neck wound infection. Laryngoscope 1987; 97: 587–91.
- Johnson JT, Bloomer WD. Effect of prior radiotherapy on postsurgical wound infection. Head Neck 1989; 11: 132–6.